Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Multiplex assays for the identification of serological signatures of SARS- CoV-2 infection: an antibody-based diagnostic and machine learning study - The Lancet Microbe

BIBLIOTECAS BUAP - #quedateencasa #utilizalabibliotecadigitalbuap #ArtículoDelDíaBibliotecasBUAP Artículo del Día Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Autores

JCM, Free Full-Text

The kinetics of humoral response and its relationship with the disease severity in COVID-19

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

Immune response in COVID-19: what is next?

Immunity to SARS‐CoV‐2 induced by infection or vaccination - Castro Dopico - 2022 - Journal of Internal Medicine - Wiley Online Library

Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines

Frontiers Viral Load in COVID-19 Patients: Implications for Prognosis and Vaccine Efficacy in the Context of Emerging SARS-CoV-2 Variants

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients - ScienceDirect